论文部分内容阅读
目的:通过蕲蛇酶和复方丹参注射液对照观察,了解蕲蛇酶对急性脑梗塞的治疗效果。方法:入组病例均为72小时之内发病的急性脑梗塞,随机分为蛇酶组(治疗组)和复方丹参组(对照组),均为60例,用药前及用药后4-6天检测血凝指标变化,并对治疗不同时间段MDS作以比较。结果:两组不同治疗时间段的MDS经协方法分析有显著差异(P<0.05);两组治疗前后血凝指标变化有显著差异(P<0.05)。提示:蕲蛇酶在治疗急性脑梗塞方面是一种安全有效的治疗药物。
OBJECTIVE: To observe the therapeutic effect of Acutobin on acute cerebral infarction by observing the viper’s enzyme and the compound Danshen injection. Methods: Acute cerebral infarction with onset within 72 hours was randomly divided into snake enzyme group (treatment group) and compound Salvia miltiorrhiza group (control group), all of which were 60 cases. Before treatment and 4-6 days after treatment Detect the change of blood coagulation index, and compare MDS for different periods of treatment. Results: There was a significant difference (P <0.05) between two groups in the analysis of MDS by different methods of treatment. There was significant difference between the two groups before and after treatment (P <0.05). Tip: Acutobin in the treatment of acute cerebral infarction is a safe and effective treatment.